Neuroendocrine Prostate Cancer (NEPC)
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Neuroendocrine Prostate Cancer (NEPC)?
There are 1 clinical trial targeting Neuroendocrine Prostate Cancer (NEPC) tracked by BioSniper.
What is the prevalence of Neuroendocrine Prostate Cancer (NEPC)?
The estimated prevalence of Neuroendocrine Prostate Cancer (NEPC) is approximately 256.0 per 100,000 population.
Deep-dive into Neuroendocrine Prostate Cancer (NEPC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis